Description
S4 is a potential treatment for conditions relating to muscle wasting, osteoporosis and benign prostatic hyperplasia. LGD is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis.
| S4 | |
| CAS Number | 19269-85-3 |
| Molar Mass | 128.3 g/mol-1 |
| Chemical Formula | S4 |
| IUPAC Name | Tetrathietane |
| LGD-4033 | |
| CAS Number | 1165910-22-4 |
| Molar Mass | 338.253 g·mol−1 |
| Chemical Formula | C14H12F6N2O |
| IUPAC Name | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile |
Reviews
There are no reviews yet.